LOFEXIDINE Drug Patent Profile
✉ Email this page to a colleague
Which patents cover Lofexidine, and what generic alternatives are available?
Lofexidine is a drug marketed by MSN, Novitium Pharma, and Regcon Holdings. and is included in three NDAs.
The generic ingredient in LOFEXIDINE is lofexidine hydrochloride. Six suppliers are listed for this compound. Additional details are available on the lofexidine hydrochloride profile page.
DrugPatentWatch® Litigation and Generic Entry Outlook for Lofexidine
A generic version of LOFEXIDINE was approved as lofexidine hydrochloride by REGCON HOLDINGS on August 20th, 2024.
AI Deep Research
Questions you can ask:
- What is the 5 year forecast for LOFEXIDINE?
- What are the global sales for LOFEXIDINE?
- What is Average Wholesale Price for LOFEXIDINE?
Summary for LOFEXIDINE
| US Patents: | 0 |
| Applicants: | 3 |
| NDAs: | 3 |
| Drug Prices: | Drug price information for LOFEXIDINE |
| DailyMed Link: | LOFEXIDINE at DailyMed |
US Patents and Regulatory Information for LOFEXIDINE
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Msn | LOFEXIDINE HYDROCHLORIDE | lofexidine hydrochloride | TABLET;ORAL | 218699-001 | Feb 24, 2025 | AB | RX | No | No | ⤷ Start Trial | ⤷ Start Trial | ⤷ Start Trial | |||
| Novitium Pharma | LOFEXIDINE HYDROCHLORIDE | lofexidine hydrochloride | TABLET;ORAL | 219917-001 | Oct 22, 2025 | AB | RX | No | No | ⤷ Start Trial | ⤷ Start Trial | ⤷ Start Trial | |||
| Regcon Holdings | LOFEXIDINE HYDROCHLORIDE | lofexidine hydrochloride | TABLET;ORAL | 218613-001 | Aug 20, 2024 | AB | RX | No | No | ⤷ Start Trial | ⤷ Start Trial | ⤷ Start Trial | |||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
